Inhibition of PCSK9 reduces infarct size and arrhythmia susceptibility in cardiac ischeamia/reperfusion injury through attenuating mitochondrial dysfunction and increasing connexin43 phosphorylation
Event: ESC Congress 2018
Topic: Lipid-Lowering Agents
Session: PCSK9 inhibitors - For the many or the few?
